News - Hybio

English

English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur

Leave Your Message

CPHI MILAN 2024

CPHI MILAN 2024

CPHI MILAN 2024

Join us in CPHI MILAN

Hybio Pharmaceutical WuHan company'Salmon Calcitonin raw material obtained the marketing approval of the State Food and Drug Administration

Hybio Pharmaceutical WuHan company'Salmon Calcitonin raw material obtained the marketing approval of the State Food and Drug Administration

Hybio Pharmaceutical WuHan company'Salmon Calcitonin raw material obtained the marketing approval of the State Food and Drug Administration

On July 1, 2024,Hybio Pharmaceutical WuHan company'Salmon Calcitonin raw material obtained the marketing approval of the State Food and Drug Administration.This development has a positive impac...

Hybio Pharmaceutical Liraglutide injection was tentatively approved by the US FDA

Hybio Pharmaceutical Liraglutide injection was tentatively approved by the US FDA

Hybio Pharmaceutical Liraglutide injection was tentatively approved by the US FDA

Review of ANDA process of Liraglutide injection in Hybio Pharmaceutical

CPHI China 2024

CPHI China 2024

CPHI China 2024

Hybio will participate in CPHI China 2024 and look forward to your arrival.

"Based in China, with a global outlook | Hybio Pharmaceuticals makes it to the ‘2023 Guangdong Top 500 Manufacturing Enterprises' list."

"Based in China, with a global outlook | Hybio Pharmaceuticals makes it to the ‘2023 Guangdong Top 500 Manufacturing Enterprises' list."

"Based in China, with a global outlook | Hybio Pharmaceuticals makes it to the ‘2023 Guangdong Top 500 Manufacturing Enterprises' list."

On November 22nd, under the guidance of the Department of Industry and Information Technology of Guangdong Province, the Development and Reform Commission of Guangdong Province, and the Department ...

Ferring Pharmaceuticals’ Senior Vice President of Global Manufacturing Supply Chain, Jens Regelin, LED a Delegation to Visit and Conduct Cooperation Exchanges with Hybio Pharmaceuticals

Ferring Pharmaceuticals’ Senior Vice President of Global Manufacturing Supply Chain, Jens Regelin, LED a Delegation to Visit and Conduct Cooperation Exchanges with Hybio Pharmaceuticals

Ferring Pharmaceuticals’ Senior Vice President of Global Manufacturing Supply Chain, Jens Regelin, LED a Delegation to Visit and Conduct Cooperation Exchanges with Hybio Pharmaceuticals

On November 2nd, Jens Regelin, Senior Vice President of Global Manufacturing Supply Chain at Ferring Pharmaceuticals, led a delegation to visit and exchange with Hybio Pharmaceuticals. Both parties...

Hybio Pharmaceuticals’ subsidiary, Pingshan Branch, completed an on-site inspection by the United States Food and Drug Administration (FDA) for current Good Manufacturing Practices (cGMP)

Hybio Pharmaceuticals’ subsidiary, Pingshan Branch, completed an on-site inspection by the United States Food and Drug Administration (FDA) for current Good Manufacturing Practices (cGMP)

Hybio Pharmaceuticals’ subsidiary, Pingshan Branch, completed an on-site inspection by the United States Food and Drug Administration (FDA) for current Good Manufacturing Practices (cGMP)

Hybio Pharmaceuticals’ subsidiary, Pingshan Branch, completed an on-site inspection by the United States Food and Drug Administration (FDA) for current Good Manufacturing Practices (cGMP) on August...